| Literature DB >> 34948441 |
Andreas S Croft1, Ysaline Roth1, Katharina A C Oswald1,2, Slavko Ćorluka1,2, Paola Bermudez-Lekerika1, Benjamin Gantenbein1,2.
Abstract
Recently, a dysregulation of the Hippo-YAP/TAZ pathway has been correlated with intervertebral disc (IVD) degeneration (IDD), as it plays a key role in cell survival, tissue regeneration, and mechanical stress. We aimed to investigate the influence of different mechanical loading regimes, i.e., under compression and torsion, on the induction and progression of IDD and its association with the Hippo-YAP/TAZ pathway. Therefore, bovine IVDs were assigned to one of four different static or complex dynamic loading regimes: (i) static, (ii) "low-stress", (iii) "intermediate-stress", and (iv) "high-stress" regime using a bioreactor. After one week of loading, a significant loss of relative IVD height was observed in the intermediate- and high-stress regimes. Furthermore, the high-stress regime showed a significantly lower cell viability and a significant decrease in glycosaminoglycan content in the tissue. Finally, the mechanosensitive gene CILP was significantly downregulated overall, and the Hippo-pathway gene MST1 was significantly upregulated in the high-stress regime. This study demonstrates that excessive torsion combined with compression leads to key features of IDD. However, the results indicated no clear correlation between the degree of IDD and a subsequent inactivation of the Hippo-YAP/TAZ pathway as a means of regenerating the IVD.Entities:
Keywords: Hippo-YAP/TAZ pathway; bioreactor; complex dynamic loading; intervertebral disc degeneration; organ culture
Mesh:
Substances:
Year: 2021 PMID: 34948441 PMCID: PMC8707270 DOI: 10.3390/ijms222413641
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1(a) Changes in the absolute IVD height under the influence of different loading regimes for seven days. Mean, N = 6–7. (b) Changes in the relative IVD height after seven days of loading with different loading regimes and compared to the initial IVD height after its dissection. Mean ± SD, N = 6–7. (c) Cell viability in the nucleus pulposus (NP) and in the annulus fibrosus (AF) at the end of each loading regime. Living cells were stained with calcein-AM (green) and dead cells with ethidium homodimer (red). Scale bar = 100 µm. Mean ± SD, n = 1–3. p-value: * < 0.05, ** < 0.01, **** < 0.0001.
Figure 2(a) GAG content in the nucleus pulposus (NP) and in the annulus fibrosus (AF) relative to their tissue dry weight. (b) GAG content in the NP and AF tissue relative to their DNA content. (c) Amount of GAG released from the IVDs into the culture medium in relation to the IVDs’ volume after their isolation from a bovine tail. (d) Amount of NO released from the IVDs into the culture medium in relation to the IVDs’ volume after their isolation from a bovine tail. Mean ± SD, N = 6–7, p-value: * <0.05, ** <0.01.
Figure 3Relative gene expression of (a,b) key genes of the Hippo-YAP/TAZ pathway, including YAP, TAZ, LATS1, and MST1; (c,d) anabolic IVD-related extracellular matrix (ECM) genes, including ACAN, COL2, and COL1; (e,f) catabolic genes, including ADAMTS4, MMP13, and MMP3; (g,h) inflammatory genes, including COX2, MCP1, and RANTES; and (i,j) genes sensitive to mechanic stimuli, including COMP and CILP, in the nucleus pulposus (NP) and in the annulus fibrosus (AF). Mean ± SD, N = 3–6, p-value: * <0.05, ** <0.01.
Figure 4Immunofluorescent pictures of the nucleus pulposus (NP) and in the annulus fibrosus (AF). The sections were stained with DAPI (blue) and anti-YAP (green) and are shown individually as well as merged. (a) NP cells at day 0, (b) NP cells after static load, (c) NP cells after low-stress load, (d) NP cells after intermediate-stress load, (e) NP cells after high-stress load, (f) AF cells at day 0, (g) AF cells after static load, (h) AF cells after low-stress load, (i) AF cells after intermediate-stress load, (j) AF cells after high-stress load. Scale bar = 100 µm.
Mechanical loading regimes applied to the explanted IVDs. Day 0 was used as a reference for all other regimes; “static load” refers to the static mechanical loading regime, and “low-stress”, “intermediate-stress” as well as “high-stress” all refer to the complex dynamic mechanical loading regimes.
| Regime | Description | |
|---|---|---|
| Day 0 | No load. Prepared for further analysis after two days of free swelling. | |
| Static load | Basal pressure of 0.1 MPa. | |
| Low-stress | Passive phase | Basal pressure of 0.1 MPa. |
| Active phase | Active pressure of 0.2 MPa alternates with a torsion of ±2° at a frequency of 0.05 Hz and a basal pressure of 0.1 MPa. | |
| Intermediate-stress | Passive phase | Basal pressure of 0.1 MPa. |
| Active phase | Active pressure of 0.4 MPa alternates with a torsion of ±8° at a frequency of 0.05 Hz and a basal pressure of 0.1 MPa. | |
| High-stress | Passive phase | Basal pressure of 0.1 MPa. |
| Active phase | Active pressure of 0.6 MPa alternates with a torsion of ±15° at a frequency of 0.05 Hz and a basal pressure of 0.1 MPa. | |
Figure 5Experimental setup of the complex dynamic loading regimes.
Overview of all genes investigated and the primers used with qPCR in this study.
| Gene Type | Full Name | Symbol | NCBI | Forward and Reverse Primer Sequences |
|---|---|---|---|---|
| Reference gene | 18S ribosomal RNA |
| 493779 | f—ACG GAC AGG ATT GAC AGA TTG |
| Anabolic | Aggrecan |
| 280985 | f—GGC ATC GTG TTC CAT TAC AG |
| Collagen Type 2, Alpha 1 Chain |
| 407142 | f—CGG GTG AAC GTG GAG AGA CA | |
| Collagen Type 1, Alpha 2 Chain |
| 282188 | f—GCC TCG CTC ACC AAC TTC | |
| Catabolic | ADAM Metallopeptidase with Thrombospondin Type 1 Motif 4 |
| 286806 | f–AGA TTT GTG GAG ACT CTG |
| Matrix Metallopeptidase 13 |
| 281914 | f–TCC TGG CTG GCT TCC TCT TC | |
| Matrix Metallopeptidase 3 |
| 281309 | f—CTT CCG ATT CTG CTG TTG CTA TG | |
| Mechanosensitive markers | Cartilage Oligomeric Matrix Protein |
| 281088 | f—TGC GAC GAC GAC ATA CAC |
| Cartilage Intermediate Layer Protein |
| 100336614 | f—AGG ACT TCG TGC TGT ATG | |
| Inflammatory markers | Cyclooxygenase 2 |
| 3283880 | f—GGT AAT CCT ATA TGC TCT C |
| Monocyte Chemoattractant Protein 1 |
| 281043 | f—TCG CCT GCT GCT ATA CAT T | |
| Regulated Upon Activation, Normally T-Expressed, And Presumably Secreted |
| 327712 | f—GTG CGA GAG TAC ATC AAC | |
| Hippo-YAP/TAZ pathway | Yes1 Associated Transcriptional Regulator |
| 100336629 | f—CAG CAC AGC CAA TTC TCC AA |
| Transcriptional Co-Activator With PDZ-Binding Motif |
| 614786 | f—AGA TGG ACA CGG GAG AAA AC | |
| Large Tumor Suppressor Kinase 1 |
| 535935 | f—CAG CAG CTG CCA GAC CTA TTA | |
| Mammalian STE20-like Protein Kinase 1 |
| 514886 | f—ATC ATG CAG CAA TGT GAC AG |